Constructing composite nanomedicine by coupling drug components with nanoparticles, preparation method and application
A nano-drug and inorganic nano-particle technology, which is applied in the direction of drug combinations, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve problems such as difficulties
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] The present invention uses microfluidic technology to synthesize Fe@Fe containing hydroxyl groups on the surface 3 o 4 The nanoparticle with core-shell structure is used as a model particle, and ginsenoside is used as a model drug to illustrate the process of the invention.
[0046] (1) However, most nanoparticles can be alloyed or hybridized with elements that are easily oxidized (such as Fe, Zn, Co, Al). Because the surface atoms of nanoparticles are very active, the surface elements have sufficient oxidized characteristics, A large number of -OH groups can be generated on the surface by aqueous solution, physiological saline, PBS buffer, etc. It can be prepared as figure 1 shown, by controlling N 2 The flow rate controls the oxygen content, and then controls the generated hydroxyl groups. Please refer to 201510395518.4. Preparation of Fe@Fe with hydroxyl groups on the surface 3 o 4 Core-shell nanoparticles.
Embodiment 2
[0067] The ginsenoside in Example 1 was replaced by paclitaxel which also contains multiple hydroxyl groups, and the nanoparticles and paclitaxel were coupled through the same process. last drug see Figure 8 As shown, due to the change of its molecular structure during the synthesis process and the use of surfactants such as PVP, the nano-medicine has better solubility in aqueous solution. Through nanoparticle-conjugated paclitaxel, because the nanoparticle itself has the function of awakening immune cells T-cells, and paclitaxel itself has a strong inhibitory effect on cell mitosis, they have a stronger synergistic effect and promote the rapid apoptosis of tumor cells. Cell and animal experiments show that the therapeutic effect of the nano-medicine on the nuclear tissue of malignant tumors such as breast cancer, ovarian cancer, liver cancer, head and neck cancer and lung cancer is 2-5 times higher than that of paclitaxel alone. , It can greatly reduce the patient's edema, ...
Embodiment 3
[0069] The ginsenoside in Example 1 was replaced by vincristine which also contains multiple hydroxyl groups, and the nanoparticles and vincristine were conjugated by the same process. last drug see Figure 9 Shown is nanoparticle conjugated vincristine. Like nanoparticle-conjugated paclitaxel, it not only improves its therapeutic effect on acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin's lymphoma, neuroblastoma and small cell lung cancer, but also adds nanoparticles to its therapeutic effect. The side effects are greatly reduced, reducing the patient's hair loss, diarrhea, fatigue, oral pain, edema, vision and confusion.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com